01 1Extrovis AG
01 1CALCIUM GLUCONATE
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-24
Pay. Date : 2023-10-03
DMF Number : 37213
Submission : 2023-07-05
Status : Active
Type : II
20
Extrovis Ag, based in Switzerland, is a pharmaceutical company.
They are recognized for Extrovis's success lies in improving healthcare through innovation.
One of their notable products is CALCIUM GLUCONATE, with a corresponding US DMF Number 37213.
Remarkably, this DMF maintains an Active status since its submission on July 05, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 24, 2023, and payment made on October 03, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
